Discontinued — last reported Q1 '24
Merck & Co. International — Sales increased by 10.0% to $8.30B in Q1 2024 compared to the prior quarter. Year-over-year, this metric grew by 6.0%, from $7.83B to $8.30B. Over 2 years (FY 2021 to FY 2023), International — Sales shows an upward trend with a 9.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful international market penetration and demand, while a decrease may signal competitive losses, regulatory headwinds, or adverse currency fluctuations.
This metric measures the total revenue generated from the sale of pharmaceutical products and services within internatio...
Standard across the pharmaceutical industry as 'International Revenue' or 'Revenue by Geography', allowing for direct comparison of global market share.
mrk_segment_int_l_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.35B | $6.88B | $6.04B | $8.56B | $8.36B | $7.64B | $7.52B | $7.83B | $8.02B | $8.25B | $7.54B | $8.30B |
| QoQ Change | — | +8.4% | -12.2% | +41.7% | -2.4% | -8.6% | -1.5% | +4.1% | +2.4% | +2.9% | -8.5% | +10.0% |
| YoY Change | — | — | — | — | +31.7% | +11.0% | +24.5% | -8.6% | -4.0% | +8.0% | +0.3% | +6.0% |